Catheter‐related blood stream infection caused by Mycobacterium chelonae in a child with myeloid leukemia associated with Down syndrome

Autor: Tomoko Fujikawa, Suguru Uemura, Yuya Aoto, Yoshinori Nambu, China Nagano, Naoko Nakatani, Nanako Nino, Nobuyuki Yamamoto, Takeshi Mori, Noriyuki Nishimura, Kazumoto Iijima

Publikováno v: Clinical Case Reports, Vol 9, Iss 2, Pp 835-840 (2021)

Abstract Rapidly growing nontuberculous mycobacteria should be considered if GPRs gram‐positive rods are detected in blood cultures 2‐3 days after the blood sample collection.

Externí odkaz: https://doaj.org/article/690b7560fa0d4dff8a12a9ae4568be52

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections

Autor: Andrew J Webb, Carly Wadle, Taylor Morrisette, Iman Ansari, Keira A. Cohen, Jeannette Bouchard, Tristan W Gore, Michael P. Veve, Sara Alosaimy, Abdalhamid M Lagnf, Michael J. Rybak, Melissa Barger, Carlos Mejia-Chew, Catessa Howard, Julie V. Philley

Publikováno v: Open Forum Infectious Diseases

Twelve patients were treated with omadacycline (OMC) as part of a multidrug regimen for Mycobacterium abscessus. The majority of infections were of pulmonary origin (7/12; 58.3%). The median (interquartile range) duration of OMC was 6.2 (4.2–11.0)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::070ccfab60405e0b2424dd20332fd989
http://europepmc.org/articles/PMC7890947

Bloodstream infections with rapidly growing nontuberculous mycobacteria

Autor: Natalia E. Castillo Almeida, Omar Abu Saleh, Madiha Fida, Hussam Tabaja, Isin Y. Comba

Publikováno v: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 25, Iss, Pp 100288-(2021)

Background: Bloodstream infections (BSI) with rapidly growing mycobacteria (RGM) resulted in recent nosocomial outbreaks predominantly in immunocompromised patients. A little is known about the clinical implications of RGM BSI with different species.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa325f60cb215d586f80f7e052b8a09e
https://doi.org/10.1016/j.jctube.2021.100288

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.